Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: NZ$4.09 Billion

As of October 2024 Agios Pharmaceuticals has a market cap of NZ$4.09 Billion. This makes Agios Pharmaceuticals the world's 3931th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

End of year Market Cap

End of Day market cap according to different sources

On Oct 16th, 2024 the market cap of Agios Pharmaceuticals was reported to be:

NZ$4.09 Billion

by Yahoo Finance

NZ$4.09 Billion

by CompaniesMarketCap

NZ$4.09 Billion

by Nasdaq

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Xencor XNCR	NZ$2.47 B	-39.49%	🇺🇸 USA
Exelixis EXEL	NZ$13.78 B	236.50%	🇺🇸 USA
Pfizer PFE	NZ$276.76 B	6,657.67%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	NZ$21.99 B	437.02%	🇺🇸 USA
GlaxoSmithKline GSK	NZ$131.76 B	3,117.42%	🇬🇧 UK
Eli Lilly LLY	NZ$1.358 T	33,065.89%	🇺🇸 USA